Description

MEDCIF-CV Tablets contain a combination of Cefixime 200 mg and Potassium Clavulanate, formulated to provide enhanced antibacterial coverage against a wide range of bacterial infections. Cefixime, a third-generation cephalosporin antibiotic, inhibits bacterial cell wall synthesis, while Potassium Clavulanate acts as a beta-lactamase inhibitor, protecting Cefixime from enzymatic degradation and improving its effectiveness against resistant organisms.

This combination is commonly prescribed for respiratory tract infections, ear, nose and throat infections, urinary tract infections, typhoid fever, and other susceptible bacterial infections. MEDCIF-CV Tablets offer improved treatment efficacy and reliable infection control when used as directed.

Key Highlights:

• Contains Cefixime 200 mg + Potassium Clavulanate

• Broad-spectrum antibacterial action

• Effective against beta-lactamase–producing bacteria

• Used in respiratory, ENT, UTI, and typhoid infections

• Enhances antibacterial efficacy and treatment success

• Suitable for outpatient antibiotic therapy

• To be used under medical supervision

Dosage and duration should be followed strictly as prescribed by the physician to ensure safe and effective treatment.

If you want Monopoly PCD Franchise In Panchkula then please contact us.